Interestingly, the small molecule inhibitor specific to the CSF-1 receptor GW2580 showed promise in decreasing MDSC recruitment and function in an in vivo tumor model, and exploration into its effectiveness in clear cell RCC should be further explored (49). Here, CSF1R is linked to neoplasm.